Jacobs Levy Equity Management’s Agilon Health AGL Stock Holding History

Jacobs Levy Equity Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.39M	Sell	31,643 -264,909	-89%	-$17.4M	0.01%	494
2026 Q1	$2.35M	Buy	296,552 +135,033	+84%	+$2.18M	0.01%	557
2025 Q4	$2.78M	Buy	161,519 +37,525	+30%	+$728K	0.01%	526
2025 Q3	$3.19M	Buy	123,994 +50,547	+69%	+$1.91M	0.01%	505
2025 Q2	$4.22M	Buy	+73,447	New	+$5.89M	0.02%	475

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jacobs Levy Equity Management's AGL Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its Agilon Health (AGL) stake by 89% in Q2 2026, selling an estimated $17.4M and leaving 31,643 shares worth $3.39M. The position accounts for 0.01% of the portfolio, ranked #494.

Jacobs Levy Equity Management first reported a position in AGL in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.22M in Q2 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Jacobs Levy Equity Management held 31,643 shares of Agilon Health worth $3.39M as of Q2 2026.
Jacobs Levy Equity Management sold 264,909 Agilon Health shares in Q2 2026, an estimated $17.4M.
Agilon Health made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #494 holding.
Jacobs Levy Equity Management first reported a position in Agilon Health in Q2 2025 and has held it in 5 quarters since.
Jacobs Levy Equity Management's Agilon Health position peaked at $4.22M in Q2 2025.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.